Text Messaging Support for People With Inflammatory Bowel Disease
Tests text message education and monitoring for people with Crohn disease or ulcerative colitis.
Plain-language title generated from the registry record
Registry title: Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management
Key facts
- Where
- Atlanta, Boston, Chapel Hill, Charlotte, Lake Success, Philadelphia, San Diego, San Francisco, and Scottsdale, United StatesSee the 9 sites
Where in United States
- Morehouse School of MedicineAtlanta, United StatesNo longer taking part
- Boston Medical CenterBoston, United StatesNo longer taking part
- UNC-Chapel Hill School of MedicineChapel Hill, United StatesNo longer taking part
- Atrium Health Levine Children'sCharlotte, United StatesNo longer taking part
- NYU Langone Health Lake SuccessLake Success, United StatesNo longer taking part
- University of PennsylvaniaPhiladelphia, United StatesNo longer taking part
- University of California San DiegoSan Diego, United StatesNo longer taking part
- University of California San Francisco-Benioff Children's HospitalSan Francisco, United StatesNo longer taking part
- Mayo Clinic - ArizonaScottsdale, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of North Carolina, Chapel Hill
- Trial code
- NCT06424769
- Record updated
- 8 July 2026
- Original description
The goal of this clinical trial is to learn whether IBD patients have better disease outcomes and feel more empowered to manage their condition if they have access to text messaging with their clinical team and if their symptoms are more regularly monitored through text-based surveys.Read full original descriptionShow less
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)
The goal of this clinical trial is to learn whether IBD patients have better disease outcomes and feel more empowered to manage their condition if they have access to text messaging with their clinical team and if their symptoms are more regularly monitored through text-based surveys.
Researchers will compare participants who have access to text-based monitoring, communication and education to participants who have access to text-based education alone. Researchers will also examine if different social and other non-medical factors impact IBD symptoms and quality of life.
All participants will:
* complete 5 brief on-line surveys over 12 months about their IBD and social risk factors, * receive IBD education content by text message up to 2 times a week.
Some participants will also:
* receive additional surveys by text to monitor their IBD progression, * have the opportunity to directly text message their IBD medical team.
Inclusion: 13+ years old with IBD (Crohn's disease, ulcerative colitis, indeterminant colitis); Followed at a participating site with an office visit (in-person or virtual) within the preceding 12 months; Have access to a mobile phone and willing and able to receive and respond to text messages; Willing to answer questions on electronic surveys; Have the ability to read text messages and answer surveys in English or Spanish.
Exclusion: IBD patients s/p surgery with a current pouch or ostomy; Unable to provide informed consent and child assent for minors.